NDUFB10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.571800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.358600E-01
Normal-vs-Stage2
2.456800E-01
Normal-vs-Stage3
8.556400E-01
Normal-vs-Stage4
7.480000E-01
Stage1-vs-Stage2
9.071400E-01
Stage1-vs-Stage3
5.213000E-01
Stage1-vs-Stage4
3.214400E-01
Stage2-vs-Stage3
3.154200E-01
Stage2-vs-Stage4
9.618600E-03
Stage3-vs-Stage4
9.635600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.776800E-01
Normal-vs-AfricanAmerican
3.320000E-01
Normal-vs-Asian
1.437970E-01
Caucasian-vs-AfricanAmerican
6.682600E-01
Caucasian-vs-Asian
8.646400E-02
AfricanAmerican-vs-Asian
5.636000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.887620E-01
Normal-vs-Female
3.592800E-01
Male-vs-Female
3.441400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.630200E-01
Normal-vs-Age(41-60Yrs)
1.897360E-01
Normal-vs-Age(61-80Yrs)
3.061000E-01
Normal-vs-Age(81-100Yrs)
5.833700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.652000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.130600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.910040E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.221400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.235400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.865000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.658800E-01
Normal-vs-Daily Drinker
1.777790E-01
Normal-vs-Weekly Drinker
3.585200E-01
Normal-vs-Occasional Drinker
1.337570E-01
Normal-vs-Social Drinker
2.725800E-01
Non Drinker-vs-Daily Drinker
1.880770E-01
Non Drinker-vs-Weekly Drinker
6.152800E-01
Non Drinker-vs-Occasional Drinker
4.728000E-01
Non Drinker-vs-Social Drinker
6.906400E-01
Daily Drinker-vs-Weekly Drinker
5.906600E-01
Daily Drinker-vs-Occasional Drinker
5.283000E-01
Daily Drinker-vs-Social Drinker
4.498600E-01
Weekly Drinker-vs-Occasional Drinker
9.560600E-01
Weekly Drinker-vs-Social Drinker
8.981000E-01
Occasional Drinker-vs-Social Drinker
8.084800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.126400E-01
Normal-vs-Grade 2
9.791800E-02
Normal-vs-Grade 3
1.153950E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.663400E-01
Grade 1-vs-Grade 3
9.464400E-01
Grade 1-vs-Grade 4
3.126400E-01
Grade 2-vs-Grade 3
7.097200E-01
Grade 2-vs-Grade 4
9.791800E-02
Grade 3-vs-Grade 4
1.153950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.017200E-01
Normal-vs-NonDiabetic
1.650810E-01
Diabetic-vs-NonDiabetic
1.391990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.387500E-02
Normal-vs-NoPancreatitis
2.525800E-01
Pancreatitis-vs-NoPancreatitis
2.567000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.553380E-01
Normal-vs-N1
2.975400E-01
N0-vs-N1
1.982970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.516570E-01
Normal-vs-TP53-NonMutant
5.179800E-01
TP53-Mutant-vs-TP53-NonMutant
6.501600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
